Furosemide Drug Interactions: Complete FDA Guide to Major Warnings

Furosemide is one of the most commonly prescribed loop diuretics in the United States, used to treat fluid overload in heart failure, kidney disease, and hypertension. However, according to FDA drug labeling, furosemide carries significant interaction risks with multiple medication classes that require careful monitoring and, in some cases, complete avoidance. This comprehensive guide reviews all major interactions documented in the U.S. FDA label for furosemide.

What the FDA Says About Furosemide Interactions

The U.S. FDA label for furosemide documents numerous drug interactions ranging from contraindicated (must not be used together) to major interactions requiring careful monitoring. These interactions fall into several critical categories: physical/chemical incompatibilities, ototoxicity risks, nephrotoxicity potential, and electrolyte balance disruptions. Understanding these interactions is essential for safe medication use.

Contraindicated Interactions: Must Avoid

According to FDA drug labeling, the following combinations should never be used together:

Ototoxic Combinations

Furosemide significantly increases the risk of hearing loss when combined with certain antibiotics and other diuretics. The FDA label warns against:

• Ethacrynic acid: Concomitant use is contraindicated due to the possibility of ototoxicity. Both are potent loop diuretics, and combining them dramatically increases the risk of permanent hearing damage.
• Aminoglycoside antibiotics: Furosemide may increase the ototoxic potential of drugs like tobramycin and other aminoglycosides, especially in patients with impaired renal function. The FDA label states this combination should be avoided except in genuine life-threatening situations.
• Macrolide antibiotics: Similar ototoxicity risks exist with this antibiotic class when combined with furosemide.

Physical/Chemical Incompatibilities

Some contraindications exist due to direct chemical reactions between drugs:

• Milrinone lactate in dextrose: The U.S. FDA label for furosemide explicitly warns that immediate chemical interaction occurs with formation of a precipitate when furosemide is injected into an IV line containing milrinone. Furosemide must never be administered in IV lines containing milrinone.
• Hyaluronidase (standard and ovine forms): FDA drug labeling documents physical or chemical incompatibility between furosemide and hyaluronidase, making concurrent administration unsafe.

Lithium Toxicity Risk

Furosemide is absolutely contraindicated with lithium. According to FDA drug labeling, furosemide reduces lithium's renal clearance, creating a high-risk scenario for lithium toxicity. Patients taking lithium should never take furosemide without explicit physician guidance and close monitoring of lithium levels.

Major Interactions: Requires Careful Monitoring

While not absolutely contraindicated, these interactions require careful renal function monitoring according to FDA documentation:

Nephrotoxic Combinations

The FDA label for furosemide warns that certain cephalosporin antibiotics may cause nephrotoxicity when combined with potent diuretics:

• Ceftazidime: Concomitant administration may result in nephrotoxicity. Renal function should be carefully monitored if this combination is necessary.
• Cefepime hydrochloride: Nephrotoxicity has been reported following concomitant administration of cephalosporins with potent diuretics like furosemide. Close renal function monitoring is essential.

Why These Interactions Occur: The Mechanism

Understanding why these interactions happen helps explain the FDA warnings:

Ototoxicity mechanism: Loop diuretics like furosemide increase fluid flow through the inner ear, and when combined with ototoxic drugs (aminoglycosides, ethacrynic acid, macrolides), this amplifies damage to hearing structures, potentially causing permanent hearing loss.

Nephrotoxicity mechanism: Furosemide's potent diuretic effect reduces renal blood flow and can concentrate certain antibiotics in kidney tissue. Some cephalosporins are already nephrotoxic, and this combination increases kidney injury risk.

Lithium toxicity mechanism: Furosemide causes sodium depletion, which leads to increased lithium reabsorption in the kidneys. This reduces lithium clearance, raising serum lithium levels to toxic concentrations rapidly.

Aminoglycoside toxicity mechanism: Diuretics alter antibiotic concentrations in serum and tissue, affecting drug distribution and increasing nephrotoxic and ototoxic potential.

Who Is at Greatest Risk?

Certain patient populations face higher interaction risks with furosemide:

• Patients with impaired renal function: Reduced kidney function amplifies ototoxicity and nephrotoxicity risks from furosemide interactions.
• Elderly patients: Age-related kidney decline increases interaction severity.
• Patients with hearing loss: Pre-existing hearing impairment makes ototoxic interactions more clinically significant.
• Patients on chronic lithium therapy: Those with bipolar disorder or other conditions requiring lithium face particularly high toxicity risk.
• Critically ill patients: Life-threatening infections sometimes require use of contraindicated antibiotics despite furosemide therapy.

What to Do If You Take Furosemide

According to FDA drug labeling guidance:

• Always inform your pharmacist and physician: Provide a complete list of all medications, including supplements. Your pharmacist can check for interactions using comprehensive databases.
• Never stop or change doses on your own: Some interactions require dose adjustment rather than discontinuation. A physician must make this decision.
• Monitor for warning signs: Watch for hearing changes, decreased urination, increased thirst, or muscle weakness—all signs of furosemide-related complications.
• Get regular kidney and electrolyte monitoring: FDA labeling recommends periodic assessment of renal function and electrolyte balance.
• Use life-threatening situation exceptions carefully: If your doctor prescribes a contraindicated combination (like aminoglycosides with furosemide) for a serious infection, expect close monitoring including kidney function tests and hearing assessments.

Bottom Line

Furosemide is a highly effective diuretic that treats serious fluid overload conditions, but according to FDA drug labeling, it carries significant interaction risks. Contraindicated combinations involving ototoxic antibiotics, ethacrynic acid, lithium, and certain IV medications should be avoided entirely. Major interactions with cephalosporins require careful renal monitoring. The responsibility for safe use falls on both healthcare providers and patients—providers must check for interactions before prescribing, and patients must communicate openly about all medications they take.

Your pharmacist is your best resource for identifying interactions before they cause harm. The most comprehensive way to check all your medications is through a dedicated drug interaction checker that accesses FDA labeling data directly.

Check all your medications now using checkdruginteractions.com—the most comprehensive drug interaction checker on the internet, powered by over 250,000 FDA-labeled drug records.